5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom

Details for Australian Patent Application No. 2009308217 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Prakash, Thazha P.; Swayze, Eric E.

Agent Davies Collison Cave

Pub. Number AU-A-2009308217

PCT Pub. Number WO2010/048549

Priority 61/149,297 02.02.09 US; 61/108,457 24.10.08 US; 61/174,137 30.04.09 US; 61/163,217 25.03.09 US; 61/239,672 03.09.09 US; 61/150,492 06.02.09 US

Filing date 23 October 2009

Wipo publication date 29 April 2010

International Classifications

A61K 31/712 (2006.01) - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/048549 Priority application(s): WO2010/048549

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009308232-Modulators of cystic fibrosis transmembrane conductance regulator

2009308214-Motor armature